|
|
|
|
Reference ranges for common blood tests
|
| |
|
| |
A reference range is a set of values used by a health professional to interpret a set of medical test results. The range is usually defined as the set of values 95% of the normal population falls within, or 2 standard deviations from the mean.
The reference range will vary, depending on the age, sex and race of a population, and even the instruments the laboratory uses to perform the tests. Furthermore, by definition, 5% of the normal population will fall outside the reference range.

Discussion
Ask a question about 'Reference ranges for common blood tests'
Start a new discussion about 'Reference ranges for common blood tests'
Answer questions from other users
|
Encyclopedia
A reference range is a set of values used by a health professional to interpret a set of medical test results. The range is usually defined as the set of values 95% of the normal population falls within, or 2 standard deviations from the mean.
The reference range will vary, depending on the age, sex and race of a population, and even the instruments the laboratory uses to perform the tests. Furthermore, by definition, 5% of the normal population will fall outside the reference range. The values given below therefore are given as examples only and should not be used to interpret individual test results. Factors other than medical conditions can affect laboratory values, such as male or female sex, diet, use of drugs (prescribed, over-the-counter and herbal remedies), and stress, as well as other more exotic factors like altitude.
All values denote blood plasma concentration, which is approximately 60-100% larger than the actual blood concentration, with the precise factor depending mainly on hematocrit. Exceptions (that is, values denoting total blood concentration) are:
- All values in Hematology - red blood cells (except hemoglobin in plasma)
- All values in Hematology - white blood cells
- Platelet count (Plt)
Sorted by concentration
A separate printable combined image is available for mass and molarity
By units
Units don't necessarily tell anything about molarity or mass.
White blood cells
Clinical biochemistry
Clinical chemistry (also known as "clinical biochemistry", "chemical pathology" or "pure blood chemistry") is the area of pathology that is generally concerned with analysis of bodily fluids.
- Items marked with a ** are part of "CHEM-7" and CHEM-20
- Items marked with a * are part of "CHEM-20", but not CHEM-7
Electrolytes and Metabolites
Electrolytes and Metabolites:
For iron and copper, some related proteins are also included.
| Test | Patient type | Lower limit | Upper limit | Unit | Comments
>-
| ** Sodium (Na) | | 135-137 | 145-147 | mmol/L or mEq/L | -
| ** Potassium (K) | | 3.5-3.6 | 5.0-5.1 | mmol/L or mEq/L | -
| Chloride (Cl) | | 95-98 | 105-107 | mmol/L or mEq/L | -
| Osmolality | | 275-280 | 295-296 | mOsm/kg | -
| Osmolarity | | Slightly less than osmolality | mOsm/l | -
|rowspan=2| Urea | | 1.2-3.0 | 3.0-7.0 | mmol/L | ** BUN - blood urea nitrogen
|-
| 7 | 18-21 | -
|rowspan=3| * Uric acid | | 0.18 | 0.48 | mmol/L | -
| Female | 2.0 | 7.0 | mg/dL | -
| Male | 2.1 | 8.5 | mg/dL | -
|rowspan=4| ** Creatinine | male | 68 | 118 | µmol/L | May be complemented with creatinine clearance
|-
| 0.8 | 1.3 | mg/dL | -
|rowspan=2| female | 68 | 98 | µmol/L | -
| 0.8 | 1.1 | mg/dL | -
| BUN/Creatinine Ratio | | 5 | 35 | - | -
|rowspan=2| ** Glucose (fasting) | | 3.8-3.9 | 6.1 | mmol/L | See also glycosylated hemoglobin (in hematology)
|-
| 65-70 | 100-110 | -
|rowspan=4| Total serum iron (TSI) | male | 65-76 | 176-198 | µg/dL | -
| female | 26-50 | 170 | -
| newborns | 100 | 250 | -
| children | 50 | 120 | -
| Total iron-binding capacity (TIBC) | | 240-262 | 450-474 | -
| Transferrin | | 204 | 360 | mg/dL | -
| Transferrin saturation | | 20 | 50 | % | -
|rowspan=2| Ferritin | Male | 12 | 300 | ng/mL | -
| Female | 12 | 150 | -
| Ammonia | | 10-20 | 35-65 | µmol/L | -
| Copper | | 70 | 150 | µg/dL | -
| Ceruloplasmin | | 15 | 60 | mg/dL | -
| Lactate (Venous) | | 4.5 | 19.8 | mg/dL | -
| Lactate (Arterial) | | 4.5 | 14.4 | mg/dL | -
| Pyruvate | | 0.3 | 0.9 | mg/dL | |
Acid and base
Test>| Lower limit | Upper limit | Unit | Comments
>-
| pH | 7.34-7.35 | 7.44-7.45 | | -
| [H+] | 36 | 44 | -
| base excess | -3 | +3 | | -
|rowspan=2| PO2 | 10 | 13-14 | kPa | -
| 75-83 | 100-105 | mmHg
|-
| Oxygen saturation | 96 | 100 | -
|rowspan=2| ** PCO2 | 4.4-4.8 | 5.8-5.9 | kPa | -
| 33-35 | 44-45 | mmHg | -
| Bicarbonate (HCO3-) | 18
| 23 | mmol/L | -
| Standard bicarbonate (SBCe) | 21-22 | 27-28 | mmol/L or mEq/L | - |
Liver function
Test>| Lower limit | Upper limit | Unit | Comments
>-
|* Total Protein | 60-63 | 78, 82, 84 | g/L | see hypoproteinemia
|-
|rowspan=2| * Albumin | 35 | 48-55 | g/L | see hypoalbuminemia
|-
| 3.5 | 4.8-5.5 | U/L | -
| Globulins | 23 | 35 | g/L | -
|rowspan=2| * Total Bilirubin | 2 | 17 | µmol/L | -
| 0.1-0.2 | 1.0-1.3 | -
|rowspan=2| * Direct Bilirubin | 0.0 | 5 | µmol/L | -
| 0 | 0.3-0.4 | -
| * Alanine transaminase (ALT) | 7-8 | 20, 56 | U/L | serum glutamic pyruvic transaminase (SGPT)
>-
| * Alkaline phosphatase (ALP) | 20,38, 50 | 70, 126, 160 | U/L | Higher in children and pregnant women.
>-
| * Gamma glutamyl transferase (GGT) | 8 | 50-78 | U/L | - |
Cardiac tests
Test>| Lower limit | Upper limit | Unit | Comments
>-
| Creatine kinase (CK) - male | 24-38 | 174 | U/L or ng/mL | -
| Creatine kinase (CK) - female | 24, 38, 96 | 140 | U/L | -
| CK-MB | 0 | 3 | ng/mL | -
| Troponin | 0 | 0.4 | ng/mL | - |
Other enzymes and proteins
Other ions and trace metals
Test>| Lower limit | Upper limit | Unit | Comments
>-
| Ionised calcium (Ca) | 1.03 | 1.23 | mmol/L | -
|rowspan=2| * Total calcium (Ca) | 2.1 | 2.8 | mmol/L | -
| 8.4-8.5 | 10.2-10.5 | mg/dL | -
| Phosphate (HPO42-) | 0.8 | 1.5 | mM | -
|rowspan=2| Inorganic phosphorus (serum) | 1.0 | 1.5 | mmol/L | -
| 3.0 | 4.5 | mg/dL | -
| Copper (Cu) | 11 | 24 | µmol/L | -
| Zinc (Zn) | 70 | 102 | µmol/L | -
| Magnesium | 1.5 | 2.0 | mEq/L | - |
Lipids
Test>| Patient type | Lower limit | Upper limit | Unit | Comments
>-
|rowspan=3| Triglycerides | 10 - 39 years | 54 | 110 | mg/dL | -
| 40 - 59 years | 70 | 150 | mg/dL | -
| > 60 years | 80 | 150 | -
|rowspan=2| * Total cholesterol | | 3.6 | 5.0-6.5 | mmol/L | -
| 120-140 | 200-250 | -
|rowspan=2| HDL cholesterol | female | 1.0 | 2.2 | mmol/L | Therapeutic targets: >1.0 mmol/L (40 mg/dL)
|-
| 50 | 110 | -
|rowspan=2| HDL cholesterol | male | 0.9 | 2.0 | -
| 45 | 100 | -
| LDL cholesterol | | 2.0-2.4 | 3.0-3.4 | mmol/L | Not valid when triglycerides >5.0 mmol/L.
>- |
Tumour markers
Test>| Lower limit | Upper limit | Unit | Comments
>-
| Alpha fetoprotein (AFP) | 0 | 44 | ng/mL | -
| Beta Human chorionic gonadotrophin (bHCG) | n/a | 5 | IU/l | -
| CA19.9 | n/a | 40 | U/ml | -
| Carcinoembryonic antigen (CEA) non-smokers at 50 years | n/a | 3.6 | µg/l | -
| Carcinoembryonic antigen (CEA) non-smokers at 70 years | n/a | 4.1 | µg/l | -
| Carcinoembryonic antigen (CEA) - smokers | n/a | 5 | µg/l | -
| Prostate specific antigen (PSA) | n/a | 4 | µg/L or ng/mL | -
| PAP | 0 | 3 | units/dL (Bodansky units) | |
Hormones
|Category||Test||Patient type||Lower limit||Upper limit||Unit
|-
|rowspan=16| Thyroid hormones || Thyroid stimulating hormone (TSH or thyrotropin) || || 0.4-0.5 || 4.5-6.0 || mIU/L or µIU/mL
|-
|rowspan=6| Free thyroxine (FT4) ||rowspan=2| Normal adult || 10-12 || 23 || pmol/L
|-
| 0.7 -0.8 || 1.4-1.5 || ng/dL
|-
| Infant 0-3 d || 2.0 || 5.0 || ng/dL
|-
| Infant 3-30 d || 0.9 || 2.2 || ng/dL
|-
| Child/Adolescent 31 d - 18 y || 0.8 || 2.0 || ng/dL
|-
| Pregnant || 0.5 || 1.0 || ng/dL
|-
|rowspan=2| Total thyroxine ||rowspan=2| ||60 || 140-160 || nmol/L
|-
| 4-5.5 || 11-12.3 || µg/dL
|-
|rowspan=2| Free triiodothyronine (FT3) || Normal adult || 0.2 || 0.5 || ng/dL
|-
| Children 2-16 y || 0.1 || 0.6 || ng/dL
|-
|rowspan=2| Total triiodothyronine ||rowspan=2| || 1.1 || 2.7 || nmol/L
|-
| 60-75 || 175-181 || ng/dL
|-
| Thyroxine-binding globulin (TBG) || || 12 || 30 || mg/L
|-
|rowspan=2| Thyroglobulin (Tg) ||rowspan=2| || 1.5|| 30 || pmol/L
|-
| 1 || 20 || µg/L
|-
|rowspan=20|Other ||rowspan=2| Adrenocorticotropic hormone (ACTH) ||rowspan=2| || 1.3 || 18 || pmol/L
|-
| 20 || 100 || pg/mL
|-
| Growth hormone (fasting) || || 0 || 5 || ng/mL
|-
| Growth hormone (arginine stimulation) || || 7 || n/a || ng/mL
|-
| Prolactin || || n/a || 14 || ng/mL
|-
| Testosterone || male || 8 || 27 || nmol/L
|-
|rowspan=2| 17 Hydroxyprogesterone || male || 0.06 || 3.0 || mg/L
|-
| Female (Follicular phase) || 0.2 || 1.0 || mg/L
|-
| 25-hydroxycholecalciferol || || 8 || 80 || ng/mL
|}
Amino acids
|Test||Patient type||Lower limit||Upper limit||Unit||Comment
|-
|rowspan=4| Homocysteine || Female 12-19 years || 3.3 || 7.2 || µmol/L ||rowspan=2| Elevated at: 10.4 umol/L
|-
| Female >60 years || 4.9 || 11.6 || µmol/L
|-
| Male 12-19 years || 4.3 || 9.9 || µmol/L ||rowspan=2| Elevated at: 11.4 umol/L
|-
| Male >60 years || 5.9 || 15.3 || µmol/L
|-
|}
Vitamins
Toxins
Test>| Patient type | Lower limit | Upper limit | Unit
>-
| Lead | | | 40 | - |
Hematology
Hematology is the branch of biology (physiology), pathology, clinical laboratory, internal medicine, and pediatrics that is concerned with the study of blood, the blood-forming organs, and blood diseases.
Red blood cells
|Test||Patient||Lower limit||Upper limit||Unit||Comments
|-
|rowspan=4| Haemoglobin (Hb) ||rowspan=2| male || 2.1 || 2.7 || mmol/L ||rowspan=2| Higher in neonates, lower in children.
|-
| 132-135 || 162-175 || g/L
|-
|rowspan=2| female || 1.9 || 2.5 || mmol/L ||rowspan=2| Sex difference negligible until adulthood.
|-
| 115-120 || 152-160 || g/L
|-
| Glycosylated hemoglobin (HbA1c) || || 4 || 5.9 || % of Hb ||
|-
|rowspan=3| Haematocrit (Hct) || male || 0.4, 0.41, 0.45 || 0.52,0.53 , 0.62 || ||
|-
| female || 0.36-0.37 || 0.46-0.48 || ||
|-
| Child || 0.31 || 0.43 || ||
|-
|rowspan=2| Hemoglobin in plasma || || 0.16 || 0.62 || µmol/L ||
|-
| || 1 || 4 || mg/dL ||
|-
|rowspan=2| Mean cell volume (MCV) || Male || 76-82 || 100-102 || fL ||rowspan=2| Cells are larger in neonates, though smaller in other children.
|-
| Female || 78 || 101 || fL
|-
| MCV standard deviation || || 35 || 47 || fL
|-
|rowspan=2| Mean cell haemoglobin (MCH) ||rowspan=2| || 0.39 || 0.54 || fmol/cell
|-
| 25-27 || 32-35 || pg/cell ||
|-
| Mean cell haemoglobin concentration (MCHC) || || 31-32 || 35-36 || g/dL
|-
|rowspan=3| Red blood cells (RBC) || male || 4.2-4.3 || 5.9, 6.2, 6.9 || x1012/L ||
|-
| Female || 3.5-3.8 || 5.5-5.8 || x1012/L ||
|-
| Infant/Child || 3.8 || 5.5 || x1012/L
||
|-
|rowspan=4| Reticulocytes || || 10 || 100 || x109/L ||
|-
| Adult || 0.5 || 1.5 || % of RBC ||
|-
| Newborn || 1.1 || 4.5 || % of RBC ||
|-
| Infant || 0.5 || 3.1 || % of RBC ||
|-
| Red blood cell distribution width (RDW) || || 11.5 || 14.5 || % || Coefficient of variation
|-
|}
White blood cells
|Test||Patient type||Lower limit||Upper limit||Unit
|-
|Rowspan=3| White Blood Cell Count (WBC.) || Adult || 4.1-4.5 || 10.9-11 ||rowspan=3|
|-
| Newborn || 9 || 30
|-
| 1 year old || 6 || 18
|-
|rowspan=3| Neutrophil granulocytes (A.K.A. grans, polys, PMNs, or segs) ||rowspan=2| Adult || 2 || 8 || x109/L
|-
| 45-54 || 62-74 || % of WBC
|-
| Newborn || 6 || 26 || x109/L
|-
|rowspan=2| Neutrophilic band forms ||rowspan=2| Adult || || 0.7 || x109/L
|-
| 3 || 5 || % of WBC
|-
|rowspan=3| Lymphocytes ||rowspan=2|Adult || 1.0 || 4.8 || x109/L
|-
| 16-25 || 33-45 || % of WBC
|-
| Newborn || 2 || 11 || x109/L
|-
|rowspan=3| Monocytes ||rowspan=2| Adult || 0.2 || 0.8 || x109/L
|-
| 3-4.0 || 7-10 || % of WBC
|-
| Newborn || 0.4 || 3.1 || x109/L
|-
|rowspan=2| Mononuclear leukocytes (Lymphocytes + monocytes) ||rowspan=2| Adult || 1.5 || 5 || x109/L
|-
| 20 || 35 || % of WBC
|-
| CD4+ cells || Adult || 0.4 || 1.8 || x109/L
|-
|rowspan=3| Eosinophil granulocytes ||rowspan=2| Adult || 0.04 || 0.45 || x109/L
|-
| 1 || 3-7 || % of WBC
|-
| Newborn || 0.02 || 0.85 || x109/L
|-
|rowspan=3| Basophil granulocytes ||rowspan=2| Adult || 0.01 || 0.2 || x109/L
|-
| 0.0 || 0.75-2 || % of WBC
|-
| Newborn || || 0.64 || x109/L
|}
Coagulation
Test>| Lower limit | Upper limit | Unit | Comments
>-
| Platelet count (Plt) | 140-150 | 350, 400, 450 | 9/L
>-
| Prothrombin time (PT) | 11-12 | 13.5, 14, 15 | s | -
| INR | 0.9 | 1.2 | | -
| Activated partial thromboplastin time (APTT) | 18-29 | 28-41 | s | -
| Thrombin clotting time (TCT) | 11 | 18 | s | -
| Fibrinogen | 1.7-1.8 | 4.2 | g/L | -
| Bleeding time | 2 | 9 | minutes | |
Immunology
See also
External links
| |
|
| |